Stay updated with breaking news from Director Huda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Strs Ohio decreased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,255 shares of the biopharmaceutical company’s stock after selling 977 shares during the quarter. Strs Ohio’s holdings […]
Prentiss Smith & Co. Inc. reduced its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,435 shares of the biopharmaceutical company’s stock after selling 153 shares during the quarter. […]
Stratos Wealth Advisors LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,309 shares of the biopharmaceutical company’s stock after acquiring an additional 266 shares during the […]
Czech National Bank grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 46.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,657 shares of the biopharmaceutical company’s stock after purchasing an additional 5,885 shares during the period. Czech National Bank’s holdings […]
Strategic Blueprint LLC boosted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,926 shares of the biopharmaceutical company’s stock after acquiring an additional 295 shares during the quarter. […]